Cargando…
Evaluating the national system for rare diseases in China from the point of drug access: progress and challenges
BACKGROUND: There are about 7000 rare diseases worldwide, of which only 5% of the diseases can be treated with medicines, showing that it’s important to improve patient access to orphan drugs. Recently, China has actively worked to set up a national system for rare diseases to improve the diagnosis...
Autores principales: | Qiao, Luyao, Liu, Xin, Shang, Junmei, Zuo, Wei, Xu, Tingting, Qu, Jinghan, Jiang, Jiandong, Zhang, Bo, Zhang, Shuyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463840/ https://www.ncbi.nlm.nih.gov/pubmed/36088349 http://dx.doi.org/10.1186/s13023-022-02507-2 |
Ejemplares similares
-
Innovation in Informatics to Improve Clinical Care and Drug Accessibility for Rare Diseases in China
por: Liu, Peng, et al.
Publicado: (2021) -
The first national action plan on depression in China: Progress and challenges
por: Li, Wen, et al.
Publicado: (2021) -
National Rare Diseases Registry System (NRDRS): China’s first nation-wide rare diseases demographic analyses
por: Guo, Jian, et al.
Publicado: (2021) -
Measurement of Health-Related Quality of Life in Individuals With Rare Diseases in China: Nation-Wide Online Survey
por: Xu, Richard Huan, et al.
Publicado: (2023) -
Respiratory Medicine in China: Progress, Challenges, and Opportunities
por: Wang, Chen, et al.
Publicado: (2013)